Skip to main content
WatersPartnership

Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026

Source: Autobound Signal API · 59 signals tracked for Waters · updated

Get Waters' live signals in Claude or ChatGPT, or by API

AskWhat changed at Waters this week? Use Autobound signals for waters.com.

What happened

Waters Corporation and Labcorp partnered to expand access to the FDA-approved BD Onclarity HPV Assay across Labcorp's nationwide laboratory network beginning in late 2026.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

MILFORD, Mass. and BURLINGTON, N.C., Oct. 23, 2026 /PRNewswire/ -- Labcorp (NYSE: LH ), a global leader of innovative and comprehensive laboratory services, and Waters Corporation (NYSE: WAT ), a global life sciences and diagnostics leader, today announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp's nationwide laboratory network beginning in late 2026. Cervical cancer is largely preventable through routine screening and early detection of human papillomavirus (HPV), yet millions of women remain overdue for recommended tests. This collaboration is designed to help address persistent cervical cancer screening gaps by bringing more accessible screening options to patients across the United States. Labcorp will provide these HPV testing options to support its clinician programs, Gaps in Care health plan programs, and Labcorp OnDemand consumer channel. 2-8 "Barriers such as privacy, access, and socioeconomic factors can make it difficult to stay current with cervical cancer screening," said Jeff Andrews, M.D., FRCSC, Vice President of Medical Affairs, Waters Advanced Diagnostics, Waters Corporation. 5-7 "We are at the start of a new era in which screening can extend beyond the clinic, enable more personalized risk assessment, and reach people who have historically been underserved. By offering greater flexibility in how and where...

Keep reading with a free account

The rest of this article, and every signal for Waters, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Partnership

What this signalsA new partnership often opens integration and co-selling work.

Location
Milford, Massachusetts, United States

The full record

From the Signal API record

Details

Ticker
NYSE:WAT

Extraction

Confidence
95%
Detected
Oct 23, 2026
signal_type
news
signal_subtype
partners_with

Use this data

Get every partnership signal for Waters and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Waters this week?”

  2. Send it to your own tools

    The Signal API returns partnership signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/14c8ec72-d865-c9d3-acca-5474d9f937f4 returns this record as JSON. POST /v1/companies/enrich returns every signal for waters.com.

{
  "signal_id": "14c8ec72-d865-c9d3-acca-5474d9f937f4",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-10-23T12:00:00+00:00",
  "company": {
    "name": "Waters",
    "domain": "waters.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/waters-and-labcorp-to-expand-access-to-cervical-cancer-screening-with-the-most-comprehensive-fda-approved-hpv-testing-option-beginning-in-late-2026-302918049.html",
    "title": "Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026",
    "ticker": "NYSE:WAT",
    "excerpt": "MILFORD, Mass. and BURLINGTON, N.C. , Oct. 23, 2026 /PRNewswire/ -- Labcorp (NYSE: LH ), a global leader of innovative and comprehensive laboratory services, and Waters Corporation (NYSE: WAT ), a global life sciences and diagnostics leader, today announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp's nationwide laboratory network beginning in late 2026. Cervical cancer is largely preventable through routine screening and early detection of human papillomavirus (HPV), yet millions of women remain overdue for recommended tests. This collaboration is designed to help address persistent cervical cancer screening gaps by bringing more accessible screening options to patients across the United States. Labcorp will provide these HPV testing options to support its clinician programs, Gaps in Care health plan programs, and Labcorp OnDemand consumer channel. 2-8 \"Barriers such as privacy, access, and socioeconomic factors can make it difficult to stay current with cervical cancer screening,\" said Jeff Andrews, M.D., FRCSC, Vice President of Medical Affairs, Waters Advanced Diagnostics, Waters Corporation. 5-7 \"We are at the start of a new era in which screening can extend beyond the clinic, enable more personalized risk assessment, and reach people who have historically been underserved. By offering greater flexibility in how and where...",
    "summary": "Waters Corporation and Labcorp partnered to expand access to the FDA-approved BD Onclarity HPV Assay across Labcorp's nationwide laboratory network beginning in late 2026.",
    "location": "Milford, Massachusetts, United States",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS636097/Waters-Corporation-Logo.jpg?id=OA3035789&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-10-23T12:00:00Z",
    "location_data": [
      {
        "city": "Milford",
        "state": "Massachusetts",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Labcorp (NYSE: LH ), a global leader of innovative and comprehensive laboratory services, and Waters Corporation (NYSE: WAT ), a global life sciences and diagnostics leader, today announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp's nationwide laboratory network beginning in late 2026.",
    "related_company_name": "Labcorp",
    "related_company_domain": "labcorp.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.